Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion - PubMed (original) (raw)
. 2001 Aug 10;276(32):30057-63.
doi: 10.1074/jbc.M100142200. Epub 2001 May 25.
Affiliations
- PMID: 11375979
- DOI: 10.1074/jbc.M100142200
Free article
Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion
A L Bulteau et al. J Biol Chem. 2001.
Free article
Abstract
Restoration of blood flow to ischemic myocardial tissue results in an increase in the production of oxygen radicals. Highly reactive, free radical species have the potential to damage cellular components. Clearly, maintenance of cellular viability is dependent, in part, on the removal of altered protein. The proteasome is a major intracellular proteolytic system which degrades oxidized and ubiquitinated forms of protein. Utilizing an in vivo rat model, we demonstrate that coronary occlusion/reperfusion resulted in declines in chymotrypsin-like, peptidylglutamyl-peptide hydrolase, and trypsin-like activities of the proteasome as assayed in cytosolic extracts. Analysis of purified 20 S proteasome revealed that declines in peptidase activities were accompanied by oxidative modification of the protein. We provide conclusive evidence that, upon coronary occlusion/reperfusion, the lipid peroxidation product 4-hydroxy-2-nonenal selectively modifies 20 S proteasome alpha-like subunits iota, C3, and an isoform of XAPC7. Occlusion/reperfusion-induced declines in trypsin-like activity were largely preserved upon proteasome purification. In contrast, loss in chymotrypsin-like and peptidylglutamyl-peptide hydrolase activities observed in cytosolic extracts were not evident upon purification. Thus, decreases in proteasome activity are likely due to both direct oxidative modification of the enzyme and inhibition of fluorogenic peptide hydrolysis by endogenous cytosolic inhibitory protein(s) and/or substrate(s). Along with inhibition of the proteasome, increases in cytosolic levels of oxidized and ubiquitinated protein(s) were observed. Taken together, our findings provide insight into potential mechanisms of coronary occlusion/reperfusion-induced proteasome inactivation and cellular consequences of these events.
Similar articles
- Proteasome inactivation upon aging and on oxidation-effect of HSP 90.
Conconi M, Friguet B. Conconi M, et al. Mol Biol Rep. 1997 Mar;24(1-2):45-50. doi: 10.1023/a:1006852506884. Mol Biol Rep. 1997. PMID: 9228280 - Impairment of proteasome function upon UVA- and UVB-irradiation of human keratinocytes.
Bulteau AL, Moreau M, Nizard C, Friguet B. Bulteau AL, et al. Free Radic Biol Med. 2002 Jun 1;32(11):1157-70. doi: 10.1016/s0891-5849(02)00816-x. Free Radic Biol Med. 2002. PMID: 12031900 - Catalytic properties of 26 S and 20 S proteasomes and radiolabeling of MB1, LMP7, and C7 subunits associated with trypsin-like and chymotrypsin-like activities.
Reidlinger J, Pike AM, Savory PJ, Murray RZ, Rivett AJ. Reidlinger J, et al. J Biol Chem. 1997 Oct 3;272(40):24899-905. doi: 10.1074/jbc.272.40.24899. J Biol Chem. 1997. PMID: 9312091 - Degradation of oxidized proteins by the 20S proteasome.
Davies KJ. Davies KJ. Biochimie. 2001 Mar-Apr;83(3-4):301-10. doi: 10.1016/s0300-9084(01)01250-0. Biochimie. 2001. PMID: 11295490 Review. - Getting in and out of the proteasome.
Glickman MH. Glickman MH. Semin Cell Dev Biol. 2000 Jun;11(3):149-58. doi: 10.1006/scdb.2000.0161. Semin Cell Dev Biol. 2000. PMID: 10906271 Review.
Cited by
- Stress-Induced Proteasome Sub-Cellular Translocation in Cardiomyocytes Causes Altered Intracellular Calcium Handling and Arrhythmias.
Neeman-Egozi S, Livneh I, Dolgopyat I, Nussinovitch U, Milman H, Cohen N, Eisen B, Ciechanover A, Binah O. Neeman-Egozi S, et al. Int J Mol Sci. 2024 Apr 30;25(9):4932. doi: 10.3390/ijms25094932. Int J Mol Sci. 2024. PMID: 38732146 Free PMC article. - Exercise training decreases the load and changes the content of circulating SDS-resistant protein aggregates in patients with heart failure with reduced ejection fraction.
Gouveia M, Schmidt C, Basilio PG, Aveiro SS, Domingues P, Xia K, Colón W, Vitorino R, Ferreira R, Santos M, Vieira SI, Ribeiro F. Gouveia M, et al. Mol Cell Biochem. 2024 Oct;479(10):2711-2722. doi: 10.1007/s11010-023-04884-z. Epub 2023 Oct 30. Mol Cell Biochem. 2024. PMID: 37902886 Free PMC article. - Inhibition of retinal ischemia-reperfusion injury in rats by inhalation of low-concentration hydrogen gas.
Otsuka M, Arai K, Yoshida T, Hayashi A. Otsuka M, et al. Graefes Arch Clin Exp Ophthalmol. 2024 Mar;262(3):823-833. doi: 10.1007/s00417-023-06262-3. Epub 2023 Oct 18. Graefes Arch Clin Exp Ophthalmol. 2024. PMID: 37851131 - Myocardial Protection and Current Cancer Therapy: Two Opposite Targets with Inevitable Cost.
Efentakis P, Andreadou I, Iliodromitis KE, Triposkiadis F, Ferdinandy P, Schulz R, Iliodromitis EK. Efentakis P, et al. Int J Mol Sci. 2022 Nov 15;23(22):14121. doi: 10.3390/ijms232214121. Int J Mol Sci. 2022. PMID: 36430599 Free PMC article. Review. - Protein Quality Control at the Sarcomere: Titin Protection and Turnover and Implications for Disease Development.
Kötter S, Krüger M. Kötter S, et al. Front Physiol. 2022 Jun 30;13:914296. doi: 10.3389/fphys.2022.914296. eCollection 2022. Front Physiol. 2022. PMID: 35846001 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous